Close Menu

NEW YORK (GenomeWeb) – Danaher today released its earnings guidance for 2017, saying that it anticipates net earnings per share of $3.13 to $3.23.

On an adjusted basis, the company expects earnings of $3.85 to $3.95 per share, which assumes core revenue growth of 3 percent to 4 percent over 2016. The current average analyst estimate for earnings per share in 2017 is $3.95.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

In Nature this week: epigenetic factors that prevent healthy aging and more.